Cardiovascular BioTherapeutics, Inc.: New Medical Treatment for Women’s Heart Disease Discussed in Dr. Stegmann’s Publication “Holding a Woman’s Heart in My Hands”

LAS VEGAS--(BUSINESS WIRE)--CardioVascular BioTherapeutics, Inc. (OTCBB: CVBT) has published a brochure authored by CVBT co-founder and cardiovascular surgeon Dr. Thomas Stegmann, titled “Holding a Woman’s Heart in My Hands.” The informative booklet addresses the unique medical issues women’s heart disease presents in both diagnosis and treatment, and how angiogenesis—the growth of new blood vessels in the heart—could be a new medical therapy to treat this disease, which kills more than 480,000 women a year, according to the American Heart Association.

MORE ON THIS TOPIC